RABERPRAZOLE SODIUM D/R (DIRECT RX)
Welcome to the PulseAid listing for the RABERPRAZOLE SODIUM D/R drug offered from DIRECT RX. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | DIRECT RX |
| NON-PROPRIETARY NAME: | RABERPRAZOLE SODIUM D/R |
| SUBSTANCE NAME: | RABEPRAZOLE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-30 |
| END MARKETING DATE: | 0000-00-00 |
RABERPRAZOLE SODIUM D/R HUMAN PRESCRIPTION DRUG Details:
| Item Description | RABERPRAZOLE SODIUM D/R from DIRECT RX |
| LABELER NAME: | DIRECT RX |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2017-10-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61919-225_5cc620a3-2d66-1ccf-e053-2a91aa0a1a91 |
| PRODUCT NDC: | 61919-225 |
| APPLICATION NUMBER: | ANDA202376 |
Other RABEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers:
